Candida albicans is a leading pathogen in infections of central venous catheters, which are frequently infused with heparin. Binding of C. albicans to medically relevant concentrations of soluble and plate-bound heparin was demonstrable by confocal microscopy and enzyme-linked immunosorbent assay (ELISA). A sequencebased search identified 34 C. albicans surface proteins containing ≥1 match to linear heparin-binding motifs. The virulence factor Int1 contained the most putative heparin-binding motifs (n = 5); peptides encompassing 2 of 5 motifs bound to heparin-Sepharose. Alanine substitution of lysine residues K805/K806 in 804QKKHQIHK811 (motif 1 of Int1) markedly attenuated biofilm formation in central venous catheters in rats, whereas alanine substitution of K1595/R1596 in 1593FKKRFFKL1600 (motif 4 of Int1) did not impair biofilm formation. Affinity-purified immunoglobulin G (IgG) recognizing motif 1 abolished biofilm formation in central venous catheters; preimmune IgG had no effect. After heparin treatment of C. albicans, soluble peptides from multiple C. albicans surface proteins were detected, such as Eno1, Pgk1, Tdh3, and Ssa1/2 but not Int1, suggesting that heparin changes candidal surface structures and may modify some antigens critical for immune recognition. These studies define a new mechanism of biofilm formation for C. albicans and a novel strategy for inhibiting catheter-associated biofilms.
Human immunodeficiency virus type 1 gp120 and Tat are known to bind to heparin [3, 4] , and many more microbial proteins bind to heparan sulfate, an identical polysaccharide with reduced sulfation [reviewed in 1]. In one study, four intracellular DNAbinding proteins from C. albicans (Gcf1, Nhp6, Htb1, Hta1) bound to heparin-Sepharose [5] . However, the amino acids that mediate microbial binding to heparin have not been identified.
Eukaryotic proteins that bind heparin express conformational or linear heparin-binding motifs (HBMs). Conformational motifs include the recently described CPC clip motif, a structural signature in which 2 cationic residues surround 1 polar residue [6, 7] . Linear HBMs are conserved sequences of basic (B) and hydropathic (X) amino acids in specific patterns identified by Cardin (XBBXBX), Weintraub (XBBBXXBX), and Sobel (XBBBXXBBBXXBBX) [1, 8, 9] . Basic amino acids, such as lysine, arginine, and, rarely, histidine, are critical for interaction with anionic sulfate or carboxylate groups in heparin through electrostatic and hydrogen bonds. For example, substitution of alanine for basic amino acids in linear HBMs in the morphogen Sonic Hedgehog abolished binding to heparin [10] . Because of the widespread use of heparin in central venous catheters, we identified linear HBMs in C. albicans surface proteins and characterized their functions in heparin binding and biofilm formation.
METHODS

Sequence-Based Search for Determination of Linear HBMs
Nonredundant proteins were identified from Gene Ontology functional annotations in the Candida Genome Database (www.candidagenome.org; Assembly 21) and relevant references [11, 12] and were mapped to Assembly 21. In the search for HBMs, basic amino acids were H, K, and R. Hydropathic amino acids were W, F, Y, L, I, C, M, G, V, S, T, A, N, P, and Q. The 159 proteins that met the search criteria were manually curated to confirm surface localization by prediction of a glycosylphosphatidylinositol anchoring sequence [13] [14] [15] [16] or by assignment to the cell surface in the Candida Genome Database.
Strains, Media, and Chemicals
C. albicans laboratory strains used in this study were BWP17wt [17] and derivatives, as described in Supplementary Table 1 . All strains were maintained at −80°C in 20% glycerol. Working cultures were plated on yeast peptone dextrose (YPD) plates (10 g of yeast extract, 20 g of peptone, 20 g of glucose, and 1.5% agar per liter) at 30°C for 48 hours then stored at 4°C.
Buffers, including Roswell Park Memorial Institute medium (RPMI)-1% HEPES and RPMI-5% MOPS (3-morpholinopropane-1-sulfonic acid), were obtained from Life Technologies. Formaldehyde was purchased from Fisher, dimethyl sulfoxide and calcofluor white from Sigma, filipin from Polysciences, and Fluoromount G from SouthernBiotech. Commercial-grade heparin was purchased from Sigma, pharmaceutical heparin (1000 U/mL preservative free or 20 000 U/mL with 1.5 mg/mL methylparaben and 0.15 mg/mL propylparaben) from AAP Pharmaceuticals, and desulfated heparin analogs from Neoparin.
Binding of Heparin-Alexa Fluor 488 to C. albicans
Heparin was labeled with Alexa Fluor 488 by a method modified from Osmond et al [18] . After purification on a PD-10 desalting column (GE Healthcare) equilibrated in autoclaved nanopure water, fractions containing the labeled material detected at 490 nm were combined and dried overnight on a SpeedVac concentrator (Savant) with heating. The resulting solid was redissolved in autoclaved nanopure water to 10 mg/ mL and stored at 4°C.
After overnight growth at 30°C in YPD, 2 × 10 7 C. albicans cells (BWP17wt) were labeled with a PKH26 Red Fluorescent Cell staining kit (Sigma), according to manufacturer's instructions, followed by Heparin-Alexa Fluor 488 (0.1 mL of 10 mg/mL solution). Organisms were incubated at 30°C with shaking (225 rpm) for 30 minutes, at which time a 0.4-mL aliquot was removed, pelleted (10 000 rpm for 3 minutes), and washed twice with phosphate-buffered saline (PBS). After reconstitution with 0.5 mL of PBS, 4′,6-diamidino-2-phenylindole dihydrochloride (Sigma, stock solution of 5 mg/mL) was added to a final concentration of 1 µg/mL and the solution allowed to stand at room temperature for 10 minutes. Cells were pelleted, washed twice with PBS, and then mounted on a microscope slide using Fluoromount G.
ELISA Techniques
Sigma heparin (fresh solution made daily), diluted to 25 U/mL in autoclaved, sterile-filtered PBS, was added as 0.1-mL aliquots (2.5 U) to each well of an allylamine-coated 96-well heparinbinding microtiter plate (BD Biosciences). In indicated experiments, equimolar amounts of desulfated heparins were added in lieu of heparin. The plate was incubated at room temperature overnight in the dark [19] . , and 1 × 10 5 colony-forming units (CFU)/mL, respectively, before application of 100 µL per well. After incubation at 30°C for 1 hour and washing with PBS, 0.1 mL of biotinylated rabbit anti-C. albicans IgG recognizing soluble proteins in a C. albicans lysate (Meridian Life Science), diluted 1:2500 in assay buffer (0.3% bovine serum albumin in PBS with 0.05% Tween 20), was added to each well. After incubation at 30°C for 1 hour and washing with PBS-Tween (0.05% Tween 20 in PBS), 0.1 mL of streptavidin alkaline phosphatase (Biolegend) diluted 1:10 000 in assay buffer was added, and the plate was incubated at 30°C for 30 minutes. After washing with PBS-Tween and alkaline phosphatase buffer (100 mmol/L Tris base, 50 µmol/L magnesium chloride, 100 mmol/L NaCl; pH 9.5.), 0.1 mL of alkaline phosphatase substrate (KPL) was added to each well for 45 minutes, and then absorbance at 595 nmol/L was read on a Beckman Coulter DTX 880. Experiments were performed in quadruplicate.
Construction of Mutants
Candida albicans genomic DNA was isolated from saturated overnight cultures using glass beads, as described elsewhere [20] . A lithium acetate method was used to transform C. albicans [17] . Plasmids and polymerase chain reaction (PCR) products were purified using kits (Fermentas) or established methods [21] . Pfu enzyme (New England Biolabs) with High Fidelity buffer was employed for all amplifications. Products were sequenced to affirm fidelity before use. Primers are described in Supplementary −/− strain VBIDM2 [22] to produce the reconstituted strain KO509. Briefly, a copy of INT1 was generated by PCR, using primers 1 and 2 with BWP17wt DNA as template and cloned into the SacI/MluI sites of pGEMHIS [17] to create pKO509. pKO509 was digested with SwaI and transformed into VBIDM2 to create the reconstituted strain KO509. PCR-mediated overlap extension mutagenesis [23] was used to produce copies of INT1 mutated at putative heparin-binding domains. Briefly, primer pairs 1 + 3 and 2 + 4 (or 1 + 5 and 2 + 6) were used to produce 2 overlapping fragments of INT1 in which putative HBMs were mutated (FKKRFFKL → FKAAFFKL or KQKKHQ →KQAAHQ), and a full-length mutated sequence was generated in a third PCR using primers 1 + 2 with the fragments as template. The mutated sequences were cloned into the SacI/MluI sites of pGEMHIS to create pKO503 and pKO507, respectively. A construct mutated at both sites ( pKO508) was produced using primers 1 + 5 and 2 + 6 with plasmid DNA pKO503 as template. Full-length mutated products cloned into pGEMHIS were used to transform VBIDM2 as described above, producing strains KO503, KO507, and KO508. The correct insertion and orientation of all constructs were confirmed by PCR. In growth curves performed with and without 100 U/mL heparin at 30°C in RPMI-HEPES, there was no difference in doubling times between the wild type, the double disruptant, the INT1 reintegrant, and the reintegrants containing alanine substitutions in motif 1, motif 4, or motif 1&4.
Identification of Peptides From C. albicans by Mass Spectrometry
Ten million (1 × 10 7 ) C. albicans were incubated with 250 U of pharmaceutical heparin (Hep + ) or without heparin (Hep − ) in RPMI-HEPES for 1 hour at 37°C on a rotator. Organisms were pelleted and discarded, and supernatants were removed. Next, 300 µL of Hep + and Hep − supernatants were incubated with 100 µL of avidin agarose beads (Thermo Scientific) for 60 minutes at room temperature on a rotator in the presence of 50 U heparin (Hep + ); an equal volume of RPMI-HEPES was substituted for heparin in the Hep − supernatants. Beads were pelleted; 100 µL of beads were incubated with 100 µL of 3.0 mol/L NaCl for 30 minutes at room temperature on a rotator. Beads were pelleted, and the supernatants were withdrawn, precipitated with an equal volume of trichloroacetic acid (TCA), incubated on ice overnight at 4°C, and stored at −80°C until analysis by mass spectroscopy. Six biological replicates of TCA-precipitated proteins from equal cellular equivalence of heparin-treated (Hep + ) and untreated (Hep − ) conditioned medium from cultures of C. albicans were solubilized in 50 µL of Laemmli buffer. Samples were subjected to buffer exchange and concentration using an Amicon Ultra 3-kDa microfuge filtration cartridge at 14 000 g for 15 minutes with 5 subsequent additions of ×1 Laemmli buffer (50 µL) between spins. The resulting retained proteins ( . The replicate sample pools were loaded onto 2 4%-12% mini gels and separated using the MOPS buffer system followed by silver staining (Sigma Proteosilver). Gel lanes from the replicates of Hep + and Hep − samples were gridded into 11 equal regions, followed by in gel trypsin digestion and extraction of peptides, as described elsewhere [24] . The recovered peptides from the gridded gel sections were analyzed by liquid chromatography coupled nanoelectrospray mass spectrometry on a TripleTOF 5600 (AB Sciex) attached to an Eksigent NanoLC ultra nanoflow system. Only proteins with a minimum of 2 peptides with Mascot peptide score indicating a peptide identity and a false discovery rate against an inverse database at <1% were reported. Semiquantitative measurements between the Hep + and Hep − proteins were generated by using a minimum of 2 tryptic peptides from each protein as surrogates for the amount of proteins from the 2 groups. This was accomplished by capturing extracted ion profiles for each peptide and comparing the monoisotopic peak intensity at the apex of the signal for the M + 2H or M + 3H signal for each peptide.
Antibody Production
A peptide corresponding to amino acids 799HKQEKQKKHQI HKV812 (motif 1 of Int1 underlined) was conjugated to KLH via an N-terminal cysteine residue (Pacific Immunology; www. pacificimmunology.com; National Institutes of Health animal welfare assurance No. A41820-01; US Department of Agriculture license 93-R-283). Two NZW rabbits were immunized once with conjugated peptide in a proprietary formulation of Freund's complete adjuvant and boosted 3 times with conjugated peptide in Freund's incomplete adjuvant. The same peptide was conjugated to cyanogen bromide-Sepharose and used for affinity purification of epitope-specific IgG. The final serum titer for both animals was >1:100 000 by ELISA. Preimmune serum and serum from bleed 3 were chromatographed on a 2-mL Protein A column (Thermo Scientific) to yield pre-and postimmune IgG.
Rat Model of Biofilm Formation
Polyethylene catheters were inserted into the jugular veins of female Sprague-Dawley rats, heparinized with 100 U/mL heparin, and clamped for 24 hours, as described elsewhere [25] . After removal of 0.5 mL for culture, the desired C. albicans strain was instilled and allowed to dwell for 24 hours before animals were euthanized. Catheters were removed aseptically, as described elsewhere [25] , and prepared for scanning electron microscopy at ×100 and ×2000 to assess biofilm formation on the intraluminal surface of the catheter. For antibody experiments, 1 × 10 7 C. albicans yeast cells (BWP17wt) were preincubated with a 1:10 dilution of preimmune IgG or affinity-purified IgG (both at 1.0 mg/mL) for 1 hour at 30°C, before injection into the catheter and retention for 24 hours.
Ethics Statement
All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Wisconsin, according to the guidelines of the Animal Welfare Act, the Institute of Laboratory Animal Resources Guide for the Care and Use of Laboratory Animals, and Public Health Service Policy.
Statistical Analyses
Statistical analyses were performed using the GraphPad Prism 6 statistical software package. The Bonferroni correction was applied whenever multiple comparisons were made.
RESULTS
Linear HBMs in C. albicans Surface Proteins
Approximately 400 C. albicans proteins have been identified in cell wall fractions from yeast or hyphae, depending upon the extraction technique [11] . The 34 proteins in Table 1 include only those with one of the following listed as the cellular component in the Candida Genome Database: cell surface, fungal cell wall, yeast cell wall, or hyphal cell wall. Three of these proteins-Als7, Pga4, and Rbt1-have glycosylphosphatidylinositol anchors. The genes encoding 11 of 34 proteins-Als7, Cat1, Dot4, Eno1, Gph1, Ino1, Rbt1, Sam2, Srb1, Ssa2, and Ugp1-are located in newly defined transcriptionally active regions that are involved in biofilm formation [26] .
No Effects of Heparin on C. albicans Growth and Morphology
Heparin at 100 U/mL-the concentration recommended to prevent clotting of central venous catheters [2] -had no effect on doubling times of planktonic yeast cells grown in YPD, RPMI-HEPES, RPMI-MOPS, or Complete Supplemental Medium (CSM). There were no differences between heparin-treated and untreated organisms in formation of hyphae, integrity of membrane sterols, or location of septin rings (Supplementary Figure) .
Binding of Heparin by C. albicans In Vitro
Deposition of soluble heparin-Alexa Fluor 488 was seen at the cell surface ( Figure 1A iii) and at the interface of adjoining yeast cells ( Figure 1A iv) . In an ELISA, binding of C. albicans to solid-phase heparin remained stable from 1.25 U (6.3 µg) to 20 U (100 µg) per well ( Figure 1B ). Absorbance increased linearly as the input of C. albicans increased from 1 × 10 4 to 4 × 10 4 CFU per well ( Figure 1C ).
Heparin's extremely high anionic charge is contributed by sulfated residues at position 2-O of iduronic acid and the 2-N and 6-O positions of glucosamine. With equimolar amounts of desulfated heparins, binding of 4 × 10 4 C. albicans was decreased by 11% when heparin was desulfated at the 2-O position (P = .003), and by 21% with desulfation at the 2-N position (P = .002; Figure 1D ). Desulfation at the 6-O position did not significantly reduce binding. The 2-O and 2-N sulfate residues are adjacent in the helical wheel structure of heparin, potentially indicating a preferential "face" for heparin binding [27] . Int1, the surface protein that encodes the largest number of putative HBMs (Table 1) , is a serodominant antigen involved in adhesion, filamentation, and virulence [28, 29] . To understand whether predicted HBMs in Int1 were functional, overlapping His-tagged polypeptides encompassing amino acids 51-385, 385-659, 656-1193, 1188-1551, and 1548-1711 of Int1 were expressed in Saccharomyces cerevisiae. Polypeptides spanning amino acids 656-1193 and amino acids 1548-1711 bound to a heparin-Sepharose column and were eluted with 0.5-1 mol/L NaCl. Polypeptides spanning amino acids 51-385, 385-659, and 1188-1551 failed to bind.
Amino acids 656-1193 encompass one potential heparinbinding site, 804QKKHQIHK (basic residues underlined; motif 1 in Table 1 ). Amino acids 1548-1711 encompass a canonical Weintraub motif 1593FKKRFFKL (motif 4 in Table 1 ) and a canonical Cardin motif 1612SHKTRA (motif 5). The 3 lysine residues and single arginine residue in motif 4 are located on the rim of a positively charged pocket that might facilitate binding via electrostatic interaction to a strong anion, such as heparin. Motif 5 did not share this conformation.
Standard PCR-mediated mutagenesis [17] was used to derive a set of isogenic mutants with alanine substitutions in basic residues in HBMs 1 and 4. In addition to the wild-type strain BWP17wt and the ▵int1 double disruptant, 4 reintegrants were made by reinsertion of a single copy of the INT1 gene into the double disruptant. The reintegrant contained 1 wild-type copy of INT1. In the remaining single-copy reintegrants, alanine substitutions were made in 2 basic residues in motif 1 (804QA AHQIHK), motif 4 (1593FKAAFFKL), or both.
Influence of HBMs on Biofilm Production in Central Venous Catheters
In a rat model of biofilm formation in heparinized jugular venous catheters [25] , the wild-type strain BWP17wt generated a profuse biofilm (Figure 2A) . Biofilm formation by the ▵int1 double disruptant was much reduced ( Figure 2B ). Reintegration of 1 wild-type copy of INT1 restored a profuse biofilm ( Figure 2C ). However, alanine substitution of lysines K805/ K806 in motif 1 greatly impaired biofilm formation ( Figure 2D ). Although alanine substitution of lysine K1595 and arginine K1596 in motif 4 did not reduce biofilm formation, the motif 1&4 mutant again produced sparse biofilm ( Figure 2E and 2F) . Preincubation of C. albicans with an affinity-purified IgG antibody recognizing motif 1 also markedly inhibited biofilm formation, although preimmune IgG had no effect ( Figure 3A and 3B). Postimmune IgG antibody recognizing motif 1 bound 10-fold more effectively to C. albicans compared to preimmune IgG, as assessed by flow cytometry ( Figure 3C ). These results show that lysines K805/K806 in motif 1 are essential for biofilm formation in vivo and that an antibody against motif 1 effectively inhibits biofilm formation.
Elution of C. albicans Surface Proteins
In other systems, heparin has been reported to cleave surface proteins [30] and change protein conformation [31] . After incubation with 250 U/mL heparin at 37°C for 1 hour, soluble peptides from >50 C. albicans surface proteins were detected in the supernatant, as determined by mass spectrometry. Peptides a Letter designations refer to descriptors found in the following sources: A, "cell wall" in the protein description obtained from the Candida Genome Database (as of January 2011); B, "cell wall" in the Gene Ontology annotation (as of January 2011) obtained from the Candida Genome Database; C, "cell wall proteins" in the review by Alberti-Segui et al [12] ; and D, "cell wall proteins" in the review by Chaffin [11] . b Weintraub motif.
c Cardin motif.
representing 12 proteins were found in supernatants of untreated organisms. Heparin treatment led to a 7-fold increase in intensity of IDVVDQAK (Eno1), a 10-fold increase in intensity of SLLDAAVK (Pgk1), and a 5-fold increase in VPTTDVS VVDLTVR (Tdh3) peptides ( Figure 4A-C) , compared with untreated organisms. The 10 proteins whose peptides were found in highest concentration in the supernatant (Table 2 ) are known to be localized to the cell surface. Six of 10-Eno1, Tdh3, Pgk1, Ssb1, and Ssa1/2-contain putative HBMs (Table 1 ) and are considered important antigens for innate and adaptive immune responses against C. albicans [32] [33] [34] [35] .
Whether the presence of these antigens in the supernatant represents protein secretion, cleavage, or another form of removal is not known; however, their displacement from the candidal cell surface may impair host recognition. Because soluble Int1 peptides were not identified after heparin treatment, Int1 remains a viable surface-expressed target for antibody therapy. 
DISCUSSION
One of a plethora of virulence mechanisms, biofilm formation in C. albicans involves numerous genes that affect adhesion, hyphal production, and secretion of extracellular matrix [36, 37] . Many of these genes are controlled by a network of 6 master transcriptional regulators [26] . In evaluating a possible relationship between C. albicans, heparin, and biofilm formation, attention to heparin concentrations used in humans is critical. Although in one study heparin concentrations (2000 to 10 000 U/mL) inhibited C. albicans growth and biofilm formation in vitro [38] , these concentrations of heparin are 2-to 100-fold greater than those routinely prescribed for use in central venous catheters [2] . Moreover, because in vitro assays of biofilm do not necessarily predict in vivo phenotypes [39] , definitive testing is best performed in vivo.
Our results show that C. albicans binds both soluble and plate-bound heparin. Sulfation at the 2-O residue of iduronic acid and the 2-N residue of glucosamine correlates positively with binding. In vivo, lysines K805/K806 of motif 1 in Int1 are essential for biofilm production in central venous catheters. An IgG antibody directed against motif 1 inhibits biofilm formation. As shown by the flow cytometry experiment (Figure 3C ), the antibody to motif 1 does not lyse the organisms. Although we do not yet know the mechanism of biofilm formation that is targeted by the antibody, there are at least possibilities. First, heparin may serve as a bridge between HBMs on individual Candida cells, thereby facilitating cell-to-cell adhesion, an important early step in biofilm formation [36] . Alternatively, heparin may also link Candida cells and heparin-binding proteins of the endothelial matrix, such as fibronectin, and thereby serve to tether the Candida cells to the endothelialized surface of the catheter.
These results have important clinical implications because of the use of heparin in central venous catheters, in which setting Candida spp. are the fourth most common cause of infections [40] . Indeed, the presence of central venous catheters is considered a major risk factor in patients at highest risk of candidemia [41] . In a comparison of chlorhexidine-and heparin-coated catheters, all candidal colonization and candidemias were found in patients who received heparin-coated catheters [42] . From this standpoint, monthly infusion of a humanized antibody directed against motif 1 might be an effective preventative for patients requiring long-term central venous catheters. Putative linear HBMs are also present in Staphylococcus epidermidis and Staphylococcus aureus ( Jason Long Lu and Margaret Hostetter, unpublished data), 2 organisms that are even more prominent causes of catheter-associated infection [40] . Both clinical and laboratory studies have implicated heparin in biofilm formation by S. aureus [43, 44] . The presence of putative linear HBMs in several organisms that figure prominently in central line-associated bloodstream infections suggests that these motifs may serve as biomarkers for organisms able to form biofilms in the presence of heparin or may, as in the case of C. albicans, directly mediate this complication. In characterizing the mechanisms underlying the interaction between C. albicans surface proteins and heparin, the studies reported here define both a new mechanism of biofilm formation and a novel strategy for inhibiting catheter-associated biofilms.
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